• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • DONATE
  • Pay 2023 Membership Dues
  • Join PeDRA
  • Login
MENUMENU
  • Contact Us
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Community Spotlight
        • Play Eczema Counts Now!
        • Patient Advisory Committee
        • Find a Pediatric Dermatologist (from SPD)
        • Parents, advocates, and patients over the age of 18 with a direct connection or significant interest in childhood skin disease or pediatric dermatology research are encouraged to join the PeDRA network for free as Community Members.

          Apply Now!

  • Education and Events
        • Virtual Education
        • PeDRA Podcasts
        • Points of Discussion Podcast
        • Mentorship Program
        • SPD/PeDRA Journal Club
        • 2022 PeDRA Annual Conference
        • Dash for Discovery Fun Run/Walk
        • Early Investigator Support
        • Play Eczema Counts Now!
        • Events Calendar
        • Save the Date! The 2023 PeDRA Annual Conference will be held November 9-11, 2023 at the Westin Buckhead Atlanta in Atlanta, GA.

           

          Listen to PeDRA’s newest podcast series, Industry 101!

  • Research
        • Grants and Fellowships
        • Resources for Researchers
        • Survey Application
        • Study Application
        • Research Areas
        • Publications
        • Now accepting applications for the Emerging Investigator Research Grants Program and Research Fellowships Program.

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports & Financials
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • 2022 marked PeDRA’s 10th year of pursuing the vision of changing lives and healing children with skin disease through collaboration and discovery. Visit our 10th Anniversary Page to learn more about the origin of PeDRA and the many accomplishments during the first ten years!

  • Member Login

Drugs & Bugs

Skin reactions to infections in children can be difficult to distinguish from reactions to medications. Children are different from adults in 2 important ways, meaning that we can’t rely on what is known about these reactions in adults without interpretation and further study. #1: Children are exposed to more infections (think of daycare) and have evolving immune responses to these bugs. #2. Adults take more medications and possibly different medications for their health conditions than children do. These differences are important because if the triggers for the reactions are different, then the treatment/management should be different and specific to children too.

In the last 5-7 years, there has been increasing recognition of the entity now preferentially referred to as RIME – reactive infectious mucocutaneous eruption – that was previously called Stevens Johnson syndrome (SJS) from infection or Mycoplasma pneumoniae-induced rash and mucositis (MIRM). This condition, a ‘bug’-related one, is triggered by many different respiratory infections but is still poorly understood. Drug-induced reactions also need further study – not only those that are blistering (toxic/drug-induced epidermal necrolysis) but other types of severe cutaneous reactions too.

The goals of the Drugs & Bugs Focused Study Group are to define and address unmet research needs in bug/infection- and drug/medication-induced skin disease in children and to advance our understanding of specific triggers, mechanisms, genetic predispositions, management, outcomes, and complications so that we can improve care for our pediatric and adolescent patients.

The Drugs & Bugs Focused Study Group at work, November 2021.

Chairs

The Drugs & Bugs Focused Study Group is co-chaired by Michele Ramien, MD at the University of Calgary, Minnelly Luu, MD at the University of Southern California, and Yasmine Kirkorian, MD at Children’s National Hospital.

Links

Studies
  • Clinical and Genetic Characterization of Recurrent Reactive Infectious Mucocutaneous Eruption
  • Consensus Management of RIME in Children and Adolescents
Studies Seeking Collaborators

Coming soon.

Publications

Coming soon.

Resources

Coming soon.

Active Member Locations

Get involved!

Send us an email to get connected to the Drugs & Bugs group or to learn more.

Email PeDRA

Footer

  • Our Membership
  • For Patients
  • For Researchers
  • Governance Policies
  • Financial Conflict of Interest Policy
  • Jobs at PeDRA
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Sign up to receive emails from PeDRA
Join PeDRA
Donate

Copyright © 2023 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy